Atlas Trials

A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma

Clinical trial NCT03840967 · TERMINATED

Trial details

NCT number
NCT03840967
Sponsor
Shadia Jalal, MD
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal CancerGastric CancerAdenocarcinoma
Start date
2019-07-09
Primary completion
2022-11-17
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.